A detailed history of Raelipskie Partnership transactions in Pfizer Inc stock. As of the latest transaction made, Raelipskie Partnership holds 14,890 shares of PFE stock, worth $369,272. This represents 0.21% of its overall portfolio holdings.

Number of Shares
14,890
Previous 15,715 5.25%
Holding current value
$369,272
Previous $440 Million 2.0%
% of portfolio
0.21%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$27.7 - $31.39 $22,852 - $25,896
-825 Reduced 5.25%
14,890 $431 Million
Q2 2024

Jul 18, 2024

BUY
$25.26 - $29.6 $6,315 - $7,400
250 Added 1.62%
15,715 $440 Million
Q1 2024

May 23, 2024

SELL
$25.89 - $29.73 $210,433 - $241,645
-8,128 Reduced 34.45%
15,465 $429 Million
Q4 2023

May 23, 2024

BUY
$26.13 - $33.94 $616,485 - $800,746
23,593 New
23,593 $679 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $139B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Raelipskie Partnership Portfolio

Follow Raelipskie Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raelipskie Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Raelipskie Partnership with notifications on news.